CEOs sign off most often. Of the 20 people who sign off, 15 are CEOs.
SourceThe list built for OptiBrand Rx, 34 accounts with the person who signs off at each, every one with a work email and a phone checked Nov 6, 2026
Buyer list for OptiBrand Rx · Checked
34 companies like AbbVie across the US that fit what OptiBrand Rx sells, each with the person who signs off.
We read optibrandrx.com to see who OptiBrand Rx already serves, then checked each account below against that, one by one, and named the person who signs off at each. Every one is open below with work email and phone, and the list is yours to keep.
Report prepared for
OptiBrand Rx
Tim Rath of Innovative Radiology on working with us
Checked
The opportunity for OptiBrand Rx
The accounts that fit what OptiBrand Rx sells, the market behind them, and who signs off.
34
accounts that fit OptiBrand Rx, each with the person who signs off
SourceThe list built for OptiBrand Rx, 34 accounts with the person who signs off at each, every one with a work email and a phone checked Nov 6, 2026
12
states on the list
SourceThe list built for OptiBrand Rx, 34 accounts with the person who signs off at each, every one with a work email and a phone checked Nov 6, 2026
27
cities on the list
SourceThe list built for OptiBrand Rx, 34 accounts with the person who signs off at each, every one with a work email and a phone checked Nov 6, 2026
01Buyer list for OptiBrand Rx
Each account is the same kind of buyer as a company OptiBrand Rx already serves, and each comes with the person who signs off, a work email and a phone, checked on . The top accounts also carry a first email written for OptiBrand Rx, and a dated public reason to reach out where one exists.
| Company | Why it fits, and a first email | Contact | Status |
|---|---|---|---|
Insmedorporated Deborah Kogan Eilender Head of Patient Marketing, ARIKAYCE New York, NY | Insmedorporated develops and delivers therapies for people living with serious diseases, the same kind of buyer as AbbVie. A first email, written for OptiBrand Rxpatient insight for ARIKAYCE Hi Deborah, Patient marketing for a therapy in a serious disease depends on knowing the people who live with it. OptiBrand Rx does healthcare brand strategy and market research for teams like yours, and AbbVie already works with us. We help brand leads hear what patients and doctors really think, then shape the story around it. Is patient insight on ARIKAYCE something your team is looking at this year? Grace | deborah.kogan | Checked |
Puretech Health Eric Elenko Co-Founder & President Boston, MA | Puretech Health develops and commercializes therapeutics and novel medicines, the same kind of buyer as AbbVie. Reason to reach out now PureTech Health secured FDA Fast Track status for an antibody from its oncology company. Asktraders, A first email, written for OptiBrand Rxbrand planning after fast track Hi Eric, PureTech Health secured FDA Fast Track status for an antibody from its oncology company. Milestones like that tend to bring brand and market questions forward. OptiBrand Rx does healthcare brand strategy and market research, and AbbVie already works with us. We help teams test how doctors, payers and patients see a new medicine before the big choices get made. Who on your side owns early brand planning for that program? Grace | ee | Checked |
Azurity Pharmaceuticals Chad Collins Chief Commercial Officer, North America Houston, TX | Azurity Pharmaceuticals develops and commercializes medicines for overlooked patients, the same kind of buyer as AbbVie. Reason to reach out now Azurity Pharmaceuticals received FDA approval for Lamlique, its lamotrigine oral suspension. GlobeNewswire, A first email, written for OptiBrand Rxbrand plan for Lamlique Hi Chad, Azurity Pharmaceuticals received FDA approval for Lamlique, its lamotrigine oral suspension. A new approval puts the launch story under pressure fast. OptiBrand Rx does healthcare brand strategy and market research for specialty pharma teams, and AbbVie already works with us. We help commercial leads learn how prescribers, caregivers and patients see a product, and shape the brand around that. How is your team building the brand plan for Lamlique? Grace | chad.collins | Checked |
Amneal Pharmaceuticals Tony Rosa Senior Vice President of Sales and Marketing, Retail Generics San Francisco, CA | Amneal Pharmaceuticals develops, manufactures, and distributes essential medicines, the same kind of buyer as AbbVie. | tony.rosa | Checked |
Acrotech Biopharma Todd Miller Head of Dermatology Marketing Scotch Plains, NJ | Acrotech Biopharma develops and commercializes biopharmaceuticals for oncology, dermatology, and neuroscience, the same kind of buyer as AbbVie. Reason to reach out now Acrotech Biopharma launched ADQUEY in the US to establish its dermatology business. Express Pharma, A first email, written for OptiBrand RxADQUEY and dermatology insight Hi Todd, Acrotech Biopharma launched ADQUEY in the US to build out its dermatology business. A first launch in a new area sets the tone for every brand after it. OptiBrand Rx does healthcare brand strategy and market research, and AbbVie already works with us. We help marketing leads learn how dermatologists and patients see a treatment, and sharpen the brand story to match. How are you tracking what dermatologists think of ADQUEY so far? Grace | tmiller | Checked |
Amarin Corporation Aaron Berg EVP & President, US at Amarin Pharma Inc Lebanon, NJ | Amarin Corporation develops therapeutics to improve cardiovascular health, the same kind of buyer as AbbVie. A first email, written for OptiBrand Rxcardiovascular brand research Hi Aaron, Cardiovascular brands face crowded conversations with doctors and patients alike. OptiBrand Rx does healthcare brand strategy and market research, and AbbVie already works with us. We help US commercial leaders learn what prescribers and patients believe about a therapy, then sharpen the brand story to fit. Who on your team owns brand research for the US business? Grace | aaron.berg | Checked |
Amylyx Pharmaceuticals Dan Monahan Chief Commercial Officer (CCO) New York | Amylyx Pharmaceuticals develops therapies for ALS and neurodegenerative diseases, the same kind of buyer as AbbVie. Reason to reach out now Amylyx Pharmaceuticals announced positive topline results from its LUCIDITY trial of avexitide in post bariatric hypoglycemia. BioSpace, A first email, written for OptiBrand Rxbrand planning for avexitide Hi Dan, Amylyx Pharmaceuticals announced positive topline results from its LUCIDITY trial of avexitide in post bariatric hypoglycemia. That moves a new area toward approval and a launch. OptiBrand Rx does healthcare brand strategy and market research, and AbbVie already works with us. We help commercial leaders learn how doctors and patients see a new condition and shape the brand early. Where is your team on brand planning for avexitide? Grace | dan_monahan | Checked |
AnaptysBio Daniel Faga President & CEO San Diego | AnaptysBio develops immunology therapeutics for autoimmune and inflammatory diseases, the same kind of buyer as AbbVie. A first email, written for OptiBrand Rximmunology brand research Hi Daniel, Immunology brands in autoimmune and inflammatory disease live in a crowded field. OptiBrand Rx does healthcare brand strategy and market research, and AbbVie already works with us. We help leadership teams learn how doctors and patients see a therapy early, so the brand story is clear before big commercial choices. Is brand research part of your plans for the pipeline this year? Grace | dfaga | Checked |
Aveo Oncology Kevin Peacock Chief Commercial Officer (CCO) at AVEO Oncology Warrington Township, PA | Aveo Oncology operates as an oncology focused biopharmaceutical company, the same kind of buyer as AbbVie. A first email, written for OptiBrand Rxoncology brand research Hi Kevin, Oncology brands have to earn trust with busy oncologists and their patients. OptiBrand Rx does healthcare brand strategy and market research, and AbbVie already works with us. We help commercial leaders learn what prescribers and patients weigh in a treatment choice, then sharpen the brand story around it. Who leads market research for your oncology brands today? Grace | kpeacock | Checked |
Brii Biosciences Zhi Hong Co-Founder and CEO Chapel Hill, NC | Brii Biosciences develops therapeutics for hepatitis B, HIV and CNS diseases, the same kind of buyer as AbbVie. | zhi.hong | Checked |
Journey Medical Corporation Robert Nevin Chief Commercial Officer Scottsdale, AZ | Journey Medical Corporation offers FDA approved dermatology pharmaceuticals for common skin conditions, the same kind of buyer as AbbVie. | rnevin | Checked |
Mirum Pharmaceuticals Lindsey Spelyng Executive Director/Brand lead, Marketing Louisville, CO | Mirum Pharmaceuticals develops pharmaceuticals, the same kind of buyer as AbbVie. | lindsey.spelyng | Checked |
Adaptive Biotechnologies Sharon Benzeno, PhD Chief Commercial Officer, Immune Medicine New York, NY | Adaptive Biotechnologies is the same kind of buyer as AbbVie. | sbenzeno | Checked |
ANI Pharmaceuticals Nikhil Lalwani President & CEO Princeton, NJ | ANI Pharmaceuticals offers Purified Cortrophin Gel for rare disease treatment, the same kind of buyer as AbbVie. | nikhil.lalwani | Checked |
ImmunityBio Charles Pigneri Brand Director ANKTIVA Kansas City | ImmunityBio develops immunotherapies for cancer and infectious diseases, the same kind of buyer as AbbVie. | charles.pigneri | Checked |
AiViva BioPharma Diane Tang-Liu Co-Founder, CEO & President Newport Beach, CA | AiViva BioPharma develops targeted drug delivery for dermatology, ophthalmology, oncology, and urology, the same kind of buyer as AbbVie. | diane | Checked |
Autobahn Therapeutics Kevin Finney Chairman and CEO Carlsbad, CA | Autobahn Therapeutics develops regenerative CNS therapies using brain targeting small molecules, the same kind of buyer as AbbVie. | kfinney | Checked |
AVM Biotechnology Theresa Deisher CEO and CSO Seattle, WA | AVM Biotechnology develops a dexamethasone formulation for cancer and autoimmunity, the same kind of buyer as AbbVie. | tdeisher | Checked |
Ashvattha Therapeutics Jeffrey Cleland Chairman, CEO & President San Francisco | Ashvattha Therapeutics develops nanomedicine for eye and brain inflammation, the same kind of buyer as AbbVie. | jcleland | Checked |
Bambusa Therapeutics Thang Ho Co-Founder & Chief Development Officer Boston, MA | Bambusa Therapeutics develops bispecific antibodies for I&I treatment, the same kind of buyer as AbbVie. | thang.ho | Checked |
Elicio Therapeutics Robert Connelly CEO Boston, MA | Elicio Therapeutics develops lymph node targeted immunotherapies for cancer, the same kind of buyer as AbbVie. | bconn451 | Checked |
HCW Biologics Hing W. Founder & CEO Hollywood, FL | HCW Biologics develops immunotherapies for aging related diseases, the same kind of buyer as AbbVie. | hingwong | Checked |
iBio Martin Brenner CEO & Cso San Diego, CA | iBio develops antibody therapeutics for obesity and cardiometabolic disease, the same kind of buyer as AbbVie. | martin.brenner | Checked |
Infinimmune Anthony Slavin Senior Vice President Cambridge, MA | Infinimmune develops drugs from complete human antibodies, the same kind of buyer as AbbVie. | anthony | Checked |
Oisín Biotechnologies Matthew Scholz Chief Executive Officer Seattle, WA | Oisín Biotechnologies develops genetic medicines targeting age related diseases, the same kind of buyer as AbbVie. | matthew.scholz | Checked |
Lexicon Pharmaceuticals Rachel Martens Chief Commercial Officer New York, NY | Lexicon Pharmaceuticals develops medicines through its approach to gene science, the same kind of buyer as AbbVie. | rmartens | Checked |
Sebela Pharmaceuticals Vic Parker Chief Commercial Officer Atlanta, GA | Sebela Pharmaceuticals develops therapies for gastrointestinal diseases and women's health, the same kind of buyer as AbbVie. | victor.parker | Checked |
Tris Pharma Regie Simmons Head of Marketing Charlotte | Tris Pharma develops therapies for ADHD, pain, addiction, and central nervous system disorders, the same kind of buyer as AbbVie. | rsimmons | Checked |
Avammune Therapeutics Arun B Papaiah Founder and CEO | Avammune Therapeutics discovers small molecule drugs for cancer treatment, the same kind of buyer as AbbVie. | arun | Checked |
Avidas Pharmaceuticals Margie Gardner President, CEO Doylestown, PA | Avidas Pharmaceuticals focuses on age related disorders in dermatology, endocrinology and women's health, the same kind of buyer as AbbVie. | margiegardner | Checked |
Avotres Inc Alex Li Chief Executive Officer Morristown, NJ | Avotres Inc. develops therapies for immunologically mediated disorders, the same kind of buyer as AbbVie. | alex.li | Checked |
Longevity Biotech Sam Gellman Co-founder and CSO Madison | Longevity Biotech develops peptide therapeutics for neurodegenerative diseases, the same kind of buyer as AbbVie. | sam | Checked |
Resolve Bio James Posada, Ph.D. CEO and Founder Miami, FL | Resolve Bio develops a lupus treatment targeting the interferon cascade, the same kind of buyer as AbbVie. | jp | Checked |
Vivreon Biosciences Milton Greenberg President San Diego, CA | Vivreon Biosciences develops small molecule therapeutics for refractory chronic diseases, the same kind of buyer as AbbVie. | milton | Checked |
02The market for OptiBrand Rx
Where the accounts on the list sit, and who signs off.
What the numbers say
03How it runs for you, from the list to the meeting.
In the engagement, intent data and fit pick the accounts. ECG's AI brain reads every reply, scores it and routes it. Your CRM and your team get the meeting, the record and the next step.
Intent and fit
Once it runs for you, intent data read with fit sets which accounts to reach first.
AI brain
ECG's own AI reads every reply, scores it and routes it to the right person.
The person who signs off
Name, title, work email and phone for each account, checked before anyone reaches out.
Workflow automation
The meeting lands in your calendar, the record lands in your CRM, and the rep gets the alert.
- Intent data
- Email replies
- LinkedIn replies
- Phone calls
- Website inquiries
- Your CRM
ECG AI brain
Reads, scores and routes
- Meeting booked
- Account scored
- Rep alerted
- Personal reply sent
- CRM record updated
- Next step scheduled
Build, Run, Own
Enquirer Consulting Group
Build. Run. Own.
Built for OptiBrand Rx
The list, the messages, the CRM link and the workflows, set up for your market.
Run live with your team for four months
We run it with your team and prove it on your own numbers.
Then you own it
We hand it over, and the system stays yours.
04What to expect
What we have achieved on our own outbound, and what happens next.
88
interested replies in one week, on our own outbound
SourceInterested replies to our own outbound, one per person, Oct 12 to Oct 18, 2026, read October 18, 2026
31
sales calls booked that same week, on our own outbound
SourceECG booking table, sales calls booked Oct 12 to Oct 18, 2026, one per person, read November 6, 2026
19
industries our own outbound runs in
SourceECG fleet plan, read October 17, 2026
These are our own results. Your numbers depend on your market and your offer.
Recent work includes outreach for BOY Machines, sent in each field rep's own name.
What happens next
Book a short callList ready
Talk to BenEnquirer Consulting Group
Talk to BenEnquirer Consulting GroupAll 34 companies like AbbVie, with the person who signs off at each.
The full list is above. If it helps, Ben walks you through it on a short call.
Book a short callTalk the list through on a call.
Ben walks you through every account, who signs off at each, and how the outreach runs for OptiBrand Rx.